Jiren Yu

6PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 14, 2025
Camrelizumab plus SOX chemotherapy as adjuvant therapy for pathological stage III gastric or gastroesophageal junction adenocarcinoma: a prospective, multicenter, single-arm, phase II trial.

Hailong Jin, Jiren Yu, Yuan Gao

|Mar 08, 2025
Prognostic Value of CD133 and SOX2 Expression After Neoadjuvant Chemotherapy in Patients With Locally Advanced Gastric Cancer.

Yang Dong, Hailong Jin, Kankai Zhu

|Oct 22, 2023
Gastric gastrointestinal stromal tumors: therapeutic strategies and long-term prognosis.

Chunhui Shou, Zhou Chen, Zhijian Li

|Dec 22, 2022
Reassessment of the recurrence risk of primary gastrointestinal stromal tumour after complete resection.

Weili Yang, Chunhui Shou, Zhou Chen

|Aug 01, 2022
Elevated preoperative controlling nutritional status (CONUT) scores as a predictor of postoperative recurrence in gastrointestinal stromal tumors.

Weili Yang, Chunhui Shou, Jiren Yu

|Apr 15, 2021
The Prognostic Value of Lymph Node Ratio after Neoadjuvant Chemotherapy in Patients with Locally Advanced Gastric Adenocarcinoma.

Kankai Zhu, Hailong Jin, Zhijian Li

Pageof 1

Frequent Collaborators

2 joint publications

Hailong Jin

1 joint publications

Kankai Zhu

1 joint publications

Zhijian Li

1 joint publications

Yuan Gao